K Pharma (4896.T) Stock Price

K Pharma Price

CLOSED
753.00
​
Market closed

K Pharma stock price

Access this data via the Eulerpool API

K Pharma business model & stock analysis

K Pharma Inc is a JP-based company operating in Pharmaceuticals industry. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 13 full-time employees. The company went IPO on 2023-10-17. K Pharma Inc is a Japan-based company mainly engaged in the pharmaceutical business. The firm operates through a single segment of research, development, manufacture, and sale of pharmaceuticals, among others. The firm is engaged in induced pluripotent stem cell (iPS) drug discovery business. Neural progenitor cells, the cells that form the basis of nerves, are created from iPS cells, cryopreserved, and then 200000 cells are transplanted by injection into the site of a patient's spinal cord injury. The firm is also engaged in the research, development, manufacture and sale of regenerative medicine products.

Frequently asked questions about K Pharma

Converted at the current exchange rate, the K Pharma share trades at 4.25 EUR (753.00 JPY).

The revenue cannot currently be calculated for K Pharma.

The profit cannot currently be calculated for K Pharma.

The P/E ratio cannot be calculated for K Pharma at the moment.

The P/S cannot be calculated for K Pharma currently.

The Eulerpool Quality Score for K Pharma is 0/10.

The ISIN of K Pharma is JP3280900006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of K Pharma is 4896.T. The ticker symbol is used to trade K Pharma shares on the stock exchange.

Fair ValueTerminal
700.29 JPY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
JPY
Initial public offering
Oct 17, 2023
ISIN
JP3280900006
Cusip
J3660B100
Market capitalization
8.74 B JPYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
6.91
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-35.92 %
Last updated Oct 10, 2026, 7:34 PM

K Pharma Peer Group

K Pharma FIGI

4896:JP · BBG017RNVR634896:JT · BBG01J9BN3K94896:JJ · BBG01J9BN3V74896:JE · BBG01J9BN3Y44896:JI · BBG01J9BN3Z34896:JU · BBG01J9BN4094896:JW · BBG01J9BN4184896:JV · BBG01J9BN427

All fundamentals and in-depth analysis of K Pharma

Our stock analysis for K Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of K Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.